Hormonal and dietary characteristics in obese human subjects with and without food addiction

Nutrients

Volumn 7, Issue 1, 2015, Pages 223-238

  Pedram, Pardis ^a   Sun, Guang ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Adipokines; Food addiction; Gut hormones; Micro macro nutrient intake; Neuropeptides

Indexed keywords

ADIPOCYTOKINE; AMYLIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM; CARBOHYDRATE; CHOLESTEROL; CILIARY NEUROTROPHIC FACTOR; CORTICOTROPIN; FAT; FOLLITROPIN; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LUTEINIZING HORMONE; NEUROPEPTIDE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POTASSIUM; PROLACTIN; PROTEIN; SELENIUM; SODIUM; THYROTROPIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; BIOLOGICAL MARKER; GASTROINTESTINAL HORMONE; GLUCOSE BLOOD LEVEL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRACE ELEMENT;

ADULT; ANTHROPOMETRIC PARAMETERS; APPETITE; ARTICLE; BODY COMPOSITION; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; DIET; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD ADDICTION; HORMONE METABOLISM; HUMAN; MALE; OBESITY; PHYSICAL ACTIVITY; QUESTIONNAIRE; ADDICTION; BLOOD; BODY WEIGHT; DIET RESTRICTION; EATING DISORDER; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; NUTRITIONAL ASSESSMENT;

ADIPOKINES; ADULT; BEHAVIOR, ADDICTIVE; BIOMARKERS; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET; ENERGY INTAKE; FASTING; FEEDING AND EATING DISORDERS; FEMALE; GASTROINTESTINAL HORMONES; HUMANS; INSULIN; ISLET AMYLOID POLYPEPTIDE; MALE; MICRONUTRIENTS; MIDDLE AGED; MOTOR ACTIVITY; NEUROPEPTIDES; NUTRITION ASSESSMENT; OBESITY; PROLACTIN; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84920260683     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7010223     Document Type: Article

References (84)

1. Obesity and Overweight. Available online: http://www.who.int/topics/obesity/en/(accessed on 31 July 2014).
2. Swinburn, B.A.; Sacks, G.; Hall, K.D.; McPherson, K.; Finegood, D.T.; Moodie, M.L.; Gortmaker, S.L. The global obesity pandemic: Shaped by global drivers and local environments. Lancet 2011, 378, 804–814.
3. Obesity in Canada. Available online: http://www.phac-aspc.gc.ca/hp-ps/hl-mvs/oic-oac/adult-eng.php (accessed on 31 July 2014).
4. Twells, L. Obesity in Newfoundland and Labrador; Newfoundland and Labrador Centre for Applied Health Research (NLCAHR): St. John’s, Canada, 2005.
5. Von Deneen, K.M.; Liu, Y. Obesity as an addiction: Why do the obese eat more? Maturitas 2011, 68, 342–345.
6. Taylor, V.H.; Curtis, C.M.; Davis, C. The obesity epidemic: The role of addiction. Can. Med. Assoc. J. 2010, 182, 327–328.
7. Gearhardt, A.N.; Corbin, W.R.; Brownell, K.D. Preliminary validation of the yale food addiction scale. Appetite 2009, 52, 430–436.
8. Pursey, K.M.; Stanwell, P.; Gearhardt, A.N.; Collins, C.E.; Burrows, T.L. The prevalence of food addiction as assessed by the Yale food addiction scale: A systematic review. Nutrients 2014, 6, 4552–4590.
9. Pedram, P.; Wadden, D.; Amini, P.; Gulliver, W.; Randell, E.; Cahill, F.; Vasdev, S.; Goodridge, A.; Carter, J.C.; Zhai, G. Food addiction: Its prevalence and significant association with obesity in the general population. PLoS One 2013, 8, doi:10.1371/journal.pone.0074832.
10. Ziauddeen, H.; Farooqi, I.S.; Fletcher, P.C. Obesity and the brain: How convincing is the addiction model? Nat. Rev. Neurosci. 2012, 13, 279–286.
11. Meule, A.; Gearhardt, A.N. Food addiction in the light of DSM-5. Nutrients 2014, 6, 3653–3671.
12. Gearhardt, A.N.; Corbin, W.R.; Brownell, K.D. Food addiction: An examination of the diagnostic criteria for dependence. J. Addict. Med. 2009, 3, 1–7.
13. Gearhardt, A.N.; White, M.A.; Masheb, R.M.; Grilo, C.M. An examination of food addiction in a racially diverse sample of obese patients with binge eating disorder in primary care settings. Compr. Psychiatry 2013, 54, 500–505.
14. Dhillo, W.S. Appetite regulation: An overview. Thyroid 2007, 17, 433–445.
15. Lutter, M.; Nestler, E.J. Homeostatic and hedonic signals interact in the regulation of food intake. J. Nutr. 2009, 139, 629–632.
16. Saper, C.B.; Chou, T.C.; Elmquist, J.K. The need to feed: Homeostatic and hedonic control of eating. Neuron 2002, 36, 199–211.
17. Ahima, R.S.; Antwi, D.A. Brain regulation of appetite and satiety. Endocrinol. Metab. Clin. N. Am. 2008, 37, 811–823.
18. Volkow, N.; Wang, G.J.; Tomasi, D.; Baler, R. Obesity and addiction: Neurobiological overlaps. Obes. Rev. 2013, 14, 2–18.
19. Avena, N.M.; Gearhardt, A.N.; Gold, M.S.; Wang, G.-J.; Potenza, M.N. Tossing the baby out with the bathwater after a brief rinse? The potential downside of dismissing food addiction based on limited data. Nat. Rev. Neurosci. 2012, 13, 514.
20. Simpson, K.A.; Bloom, S.R. Appetite and hedonism: Gut hormones and the brain. Endocrinol. Metab. Clin. N. Am. 2010, 39, 729–743.
21. Murray, S.; Tulloch, A.; Gold, M.S.; Avena, N.M. Hormonal and neural mechanisms of food reward, eating behaviour and obesity. Nat. Rev. Neurosci. 2014, 10, 540–5doi:10.1038/nrendo.2014.91.
22. Kanda, H.; Tateya, S.; Tamori, Y.; Kotani, K.; Hiasa, K.-I.; Kitazawa, R.; Kitazawa, S.; Miyachi, H.; Maeda, S.; Egashira, K. Mcp-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Investig. 2006, 116, 1494–1505.
23. Kos, K.; Harte, A.L.; James, S.; Snead, D.R.; O’Hare, J.P.; McTernan, P.G.; Kumar, S. Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass. Am. J. Physiol. Endocrinol. Metab. 2007, 293, 1335–1340.
24. Arora, S. Role of neuropeptides in appetite regulation and obesity—A review. Neuropeptides 2006, 40, 375–401.
25. Hegadoren, K.; O’Donnell, T.; Lanius, R.; Coupland, N.; Lacaze-Masmonteil, N. The role of β-endorphin in the pathophysiology of major depression. Neuropeptides 2009, 43, 341–353.
26. Dinas, P.; Koutedakis, Y.; Flouris, A. Effects of exercise and physical activity on depression. Ir. J. Med. Sci. 2011, 180, 319–325.
27. Claustrat, B.; Brun, J.; Chazot, G. The basic physiology and pathophysiology of melatonin. Sleep Med. Rev. 2005, 9, 11–24.
28. Nakabayashi, M.; Suzuki, T.; Takahashi, K.; Totsune, K.; Muramatsu, Y.; Kaneko, C.; Date, F.; Takeyama, J.; Darnel, A.D.; Moriya, T. Orexin-A expression in human peripheral tissues. Mol. Cell. Endocrinol. 2003, 205, 43–50.
29. Hoggard, N.; Johnstone, A.M.; Faber, P.; Gibney, E.R.; Elia, M.; Lobley, G.; Rayner, V.; Horgan, G.; Hunter, L.; Bashir, S. Plasma concentrations of α-msh, agrp and leptin in lean and obese men and their relationship to differing states of energy balance perturbation. Clin. Endocrinol. 2004, 61, 31–39.
30. Li, J.; O’Connor, K.L.; Hellmich, M.R.; Greeley, G.H.; Townsend, C.M.; Evers, B.M. The role of protein kinase D in neurotensin secretion mediated by protein kinase C-α/-δ and rho/rho kinase. J. Biol. Chem. 2004, 279, 28466–28474.
31. Reda, T.K.; Geliebter, A.; Pi-Sunyer, F.X. Amylin, food intake, and obesity. Obes. Res. 2002, 10, 1087–1091.
32. Romanatto, T.; Cesquini, M.; Amaral, M.E.; Roman, É.A.; Moraes, J.C.; Torsoni, M.A.; Cruz-Neto, A.P.; Velloso, L.A. Tnf-α acts in the hypothalamus inhibiting food intake and increasing the respiratory quotient—Effects on leptin and insulin signaling pathways. Peptides 2007, 28, 1050–1058.
33. Zilberter, T. Food addiction and obesity: Do macronutrients matter? Front. Neuroenerg. 2012, 4, doi:10.3389/fnene.2012.00007.
34. Kant, A.; Graubard, B. Energy density of diets reported by american adults: Association with food group intake, nutrient intake, and body weight. Int. J. Obes. 2005, 29, 950–956.
35. Via, M. The malnutrition of obesity: Micronutrient deficiencies that promote diabetes. ISRN Endocrinol. 2012, 2012, doi:10.5402/2012/103472.
36. Word Health Organization. BMI Classification. Available online: http://apps.who.int/bmi/index. jsp?introPage=intro_3.html (accessed on 29 December 2014).
37. Shea, J.; King, M.; Yi, Y.; Gulliver, W.; Sun, G. Body fat percentage is associated with cardiometabolic dysregulation in bmi-defined normal weight subjects. Nutr. Metab. Cardiovasc. Dis. 2012, 22, 741–747.
38. Kennedy, A.P.; Shea, J.L.; Sun, G. Comparison of the classification of obesity by BMI vs. dual-energy X-ray absorptiometry in the newfoundland population. Obesity 2009, 17, 2094–2099.
39. Willett, W.C.; Sampson, L.; Stampfer, M.J.; Rosner, B.; Bain, C.; Witschi, J.; Hennekens, C.H.; Speizer, F.E. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am. J. Epidemiol. 1985, 122, 51–65.
40. Green, K.K.; Shea, J.L.; Vasdev, S.; Randell, E.; Gulliver, W.; Sun, G. Higher dietary protein intake is associated with lower body fat in the newfoundland population. Clin. Med. Insights Endocrinol. Diabetes 2010, 3, 25–35.
41. Cahill, F.; Shahidi, M.; Shea, J.; Wadden, D.; Gulliver, W.; Randell, E.; Vasdev, S.; Sun, G. High dietary magnesium intake is associated with low insulin resistance in the newfoundland population. PLoS One 2013, 8, doi:10.1371/journal.pone.0058278.
42. Shea, J.L.; Randell, E.W.; Sun, G. The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry. Obesity 2011, 19, 624–630.
43. Shea, J.L.; Loredo-Osti, J.C.; Sun, G. Association of RBP4 gene variants and serum HDL cholesterol levels in the newfoundland population. Obesity 2010, 18, 1393–1397.
44. Baecke, J.; Burema, J.; Frijters, J. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am. J. Clin. Nutr. 1982, 36, 936–942.
45. Van Poppel, M.N.; Chinapaw, M.J.; Mokkink, L.B.; van Mechelen, W.; Terwee, C.B. Physical activity questionnaires for adults: A systematic review of measurement properties. Sports Med. 2010, 40, 565–600.
46. Manji, N.; Boelaert, K.; Sheppard, M.; Holder, R.; Gough, S.; Franklyn, J. Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects. Clin. Endocrinol. 2006, 64, 125–128.
47. Nyrnes, A.; Jorde, R.; Sundsfjord, J. Serum TSH is positively associated with BMI. Int. J. Obes. 2005, 30, 100–105.
48. Bastemir, M.; Akin, F.; Alkis, E.; Kaptanoglu, B. Obesity is associated with increased serum TSH level, independent of thyroid function. Swiss Med. Wkly. 2007, 137, 431–434.
49. Baptista, T.; Lacruz, A.; Meza, T.; Contreras, Q.; Delgado, C.; Mejias, M.A.; Hernàndez, L. Antipsychotic drugs and obesity: Is prolactin involved? Can. J. Psychiatry Rev. Can. Psychiatr. 2001, 46, 829–834.
50. Friedrich, N.; Rosskopf, D.; Brabant, G.; Völzke, H.; Nauck, M.; Wallaschofski, H. Associations of anthropometric parameters with serum TSH, prolactin, IGF-I, and testosterone levels: Results of the study of health in pomerania (ship). Exp. Clin. Endocrinol. Diabetes 2010, 118, 266–273.
51. Kenna, G.A.; Swift, R.M.; Hillemacher, T.; Leggio, L. The relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humans. Neuropsychol. Rev. 2012, 22, 211–228.
52. Gozashti, M.H.; Mohammadzadeh, E.; Divsalar, K.; Shokoohi, M. The effect of opium addiction on thyroid function tests. J. Diabetes Metab. Disord. 2014, 13, doi:10.1186/2251-6581-13-5.
53. Vescovi, P.; Pezzarossa, A. Thyrotropin-releasing hormone-induced GH release after cocaine withdrawal in cocaine addicts. Neuropeptides 1999, 33, 522–525.
54. Moshtaghi-Kashanian, G.R.; Esmaeeli, F.; Dabiri, S. Enhanced prolactin levels in opium smokers. Addict. Biol. 2005, 10, 345–349.
55. Hermann, D.; Heinz, A.; Mann, K. Dysregulation of the hypothalamic-pituitary-thyroid axis in alcoholism. Addiction 2002, 97, 1369–1381.
56. Ellingboe, J.; Mendelson, J.H.; Kuehnle, J.C. Effects of heroin and naltrexone on plasma prolactin levels in man. Pharmacol. Biochem. Behav. 1980, 12, 163–165.
57. Patkar, A.A.; Hill, K.P.; Sterling, R.C.; Gottheil, E.; Berrettini, W.H.; Weinstein, S.P. Serum prolactin and response to treatment among cocaine-dependent individuals. Addict. Biol. 2002, 7, 45–53.
58. Wilhelm, J.; Heberlein, A.; Karagülle, D.; Gröschl, M.; Kornhuber, J.; Riera, R.; Frieling, H.; Bleich, S.; Hillemacher, T. Prolactin serum levels during alcohol withdrawal are associated with the severity of alcohol dependence and withdrawal symptoms. Alcohol.: Clin. Expe. Res. 2011, 35, 235–239.
59. Park, H.S.; Park, J.Y.; Yu, R. Relationship of obesity and visceral adiposity with serum concentrations of crp, TNF-α and IL-6. Diabetes Res. Clin. Pract. 2005, 69, 29–35.
60. Achur, R.N.; Freeman, W.M.; Vrana, K.E. Circulating cytokines as biomarkers of alcohol abuse and alcoholism. J. Neuroimmune Pharmacol. 2010, 5, 83–91.
61. Yan, Y.; Nitta, A.; Koseki, T.; Yamada, K.; Nabeshima, T. Dissociable role of tumor necrosis factor alpha gene deletion in methamphetamine self-administration and cue-induced relapsing behavior in mice. Psychopharmacology 2012, 221, 427–436.
62. Baldwin, G.C.; Tashkin, D.P.; Buckley, D.M.; Park, A.N.; Dubinett, S.M.; Roth, M.D. Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am. J. Respir. Crit. Care Med. 1997, 156, 1606–1613.
63. Irwin, M.R.; Olmstead, R.; Valladares, E.M.; Breen, E.C.; Ehlers, C.L. Tumor necrosis factor antagonism normalizes rapid eye movement sleep in alcohol dependence. Biol. Psychiatry 2009, 66, 191–195.
64. Sacerdote, P.; Franchi, S.; Gerra, G.; Leccese, V.; Panerai, A.E.; Somaini, L. Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function. Brain Behav. Immun. 2008, 22, 606–613.
65. Yamada, K.; Nabeshima, T. Pro-and anti-addictive neurotrophic factors and cytokines in psychostimulant addiction: Mini review. Ann. N. Y. Acad. Sci. 2004, 1025, 198–204.
66. Sáez, C.G.; Olivares, P.; Pallavicini, J.; Panes, O.; Moreno, N.; Massardo, T.; Mezzano, D.; Pereira, J. Increased number of circulating endothelial cells and plasma markers of endothelial damage in chronic cocaine users. Thromb. Res. 2011, 128, 18–23.
67. McClung, C.A. Circadian rhythms, the mesolimbic dopaminergic circuit, and drug addiction. Sci. World J. 2007, 7, 194–202.
68. Peniston, E.G.; Kulkosky, P.J. Α-θ brainwave training and β-endorphin levels in alcoholics. Alcohol. Clin. Exp. Res. 1989, 13, 271–279.
69. Lovallo, W.R. Cortisol secretion patterns in addiction and addiction risk. Int. J. Psychophysiol. 2006, 59, 195–202.
70. Koob, G.F.; le Moal, M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24, 97–129.
71. Eller, L.K.; Ainslie, P.N.; Poulin, M.J.; Reimer, R.A. Differential responses of circulating amylin to high-fat vs. high-carbohydrate meal in healthy men. Clin. Endocrinol. 2008, 68, 890–897.
72. Troy, L.M.; Jacques, P.F.; Hannan, M.T.; Kiel, D.P.; Lichtenstein, A.H.; Kennedy, E.T.; Booth, S.L. Dihydrophylloquinone intake is associated with low bone mineral density in men and women. Am. J. Clin. Nutr. 2007, 86, 504–508.
73. Rockett, H.R.; Breitenbach, M.; Frazier, A.L.; Witschi, J.; Wolf, A.M.; Field, A.E.; Colditz, G.A. Validation of a youth/adolescent food frequency questionnaire. Prev. Med. 1997, 26, 808–816.
74. Feskanich, D.; Rimm, E.B.; Giovannucci, E.L.; Colditz, G.A.; Stampfer, M.J.; Litin, L.B.; Willett, W.C. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J. Am. Diet. Assoc. 1993, 93, 790–796.
75. Meule, A.; Vögele, C.; Kübler, A. German translation and validation of the yale food addiction scale. Diagnostica 2012, 58, 115–126.
76. Clark, S.M.; Saules, K.K. Validation of the yale food addiction scale among a weight-loss surgery population. Eat. Behav. 2013, 14, 216–219.
77. Rogers, P.J.; Smit, H.J. Food craving and food “addiction”: A critical review of the evidence from a biopsychosocial perspective. Pharmacol. Biochem. Behav. 2000, 66, 3–14.
78. Corwin, R.L.; Grigson, P.S. Symposium overview—Food addiction: Fact or fiction? J. Nutr. 2009, 139, 617–619.
79. Panicker, V.; Evans, J.; Bjøro, T.; Åsvold, B.O.; Dayan, C.M.; Bjerkeset, O. A paradoxical difference in relationship between anxiety, depression and thyroid function in subjects on and not on T4: Findings from the hunt study. Clin. Endocrinol. 2009, 71, 574–580.
80. Sabeen, S.; Chou, C.; Holroyd, S. Abnormal thyroid stimulating hormone (TSH) in psychiatric long-term care patients. Arch. Gerontol. Geriatr. 2010, 51, 6–8.
81. Plotsky, P.M.; Owens, M.J.; Nemeroff, C.B. Psychoneuroendocrinology of depression: Hypothalamic-pituitary-adrenal axis. Psychiatr. Clin. N. Am. 1998, 21, 293–307.
82. Chandrashekara, S.; Jayashree, K.; Veeranna, H.; Vadiraj, H.; Ramesh, M.; Shobha, A.; Sarvanan, Y.; Vikram, Y.K. Effects of anxiety on TNF-α levels during psychological stress. J. Psychosom. Res. 2007, 63, 65–69.
83. Raison, C.L.; Capuron, L.; Miller, A.H. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27, 24–31.
84. Himmerich, H.; Fulda, S.; Linseisen, J.; Seiler, H.; Wolfram, G.; Himmerich, S.; Gedrich, K.; Kloiber, S.; Lucae, S.; Ising, M. Depression, comorbidities and the TNF-α system. Eur. Psychiatry 2008, 23, 421–429.